Cargando…
The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
Alzheimer’s disease (AD), the most common form of dementia in the elderly, is characterized by two neuropathological hallmarks: senile plaques, which are composed of Aβ peptides, and neurofibrillary tangles, which are composed of hyperphosphorylated TAU protein. Diabetic patients with dysregulated i...
Autores principales: | Hettich, Moritz M., Matthes, Frank, Ryan, Devon P., Griesche, Nadine, Schröder, Susanne, Dorn, Stephanie, Krauß, Sybille, Ehninger, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099345/ https://www.ncbi.nlm.nih.gov/pubmed/25025689 http://dx.doi.org/10.1371/journal.pone.0102420 |
Ejemplares similares
-
Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
por: Schweiger, Susann, et al.
Publicado: (2017) -
Regulation of mRNA Translation by MID1: A Common Mechanism of Expanded CAG Repeat RNAs
por: Griesche, Nadine, et al.
Publicado: (2016) -
Correction: The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
Publicado: (2014) -
Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis
por: Matthes, Frank, et al.
Publicado: (2018) -
Adult-Onset Fluoxetine Treatment Does Not Improve Behavioral Impairments and May Have Adverse Effects on the Ts65Dn Mouse Model of Down Syndrome
por: Heinen, Markus, et al.
Publicado: (2012)